Antithrombotic Anticoagulants

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Dr. Andrés Rodríguez - 17 April, 2026 0

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

Dr. Juan Manuel Pérez - 16 April, 2026 0

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

Dr. Omar Tupayachi - 14 April, 2026 0

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy

Ticagrelor vs. Clopidogrel in ST elevation MI: Pros and cons

Last News

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

Institutional News

Fellow’s Corner – Case 1: Chronic Total Occlusion Treated via Retrograde Approach. A True Challenge

Call For Science SOLACI & SBHCI 2026 – Submit Your Work!

Watch again “Ultrasound Pulses + Calcium = Coronary Lithotripsy” | SOLACI Technicians Webinar

Access